Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease

被引:55
作者
Takakubo, F
Yamamoto, M
Ogawa, N
Yamashita, Y
Mizuno, Y
Kondo, I
机构
[1] EHIME UNIV,SCH MED,DEPT HYG,MATSUYAMA,EHIME 79102,JAPAN
[2] KAGAWA PREFECTURAL CENT HOSP,DEPT NEUROL,KAGAWA,JAPAN
[3] OKAYAMA UNIV,SCH MED,INST MOL & CELLULAR MED,DEPT NEUROSCI,OKAYAMA 700,JAPAN
[4] MATSUYAMA RED CROSS HOSP,DEPT NEUROL,MATSUYAMA,EHIME,JAPAN
[5] JUNTENDO UNIV,SCH MED,DEPT NEUROL,TOKYO 113,JAPAN
关键词
Parkinson's disease (PD); cytochrome P450IA1 gene (CYPIA1); genetic risk factor; association;
D O I
10.1007/BF01273362
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Idiopathic Parkinson's disease (PD) is a multifactorial neurodegenerative disorder resulting from environmental factors acting on genetically susceptible individuals with normal aging. Cytochrome P450IA1 is a dioxin-inducible enzyme which is responsible for the activation of procarcinogens and environmental pollutants, such as benzo[a]pyrene and other aromatic hydrocarbons. The frequencies of polymorphic alleles of cytochrome P450IA1 gene (CYPIA1) were studied in 126 unrelated patients with PD in comparison with 176 healthy Japanese. The frequency of the Msp I polymorphic allele, a variant of CYPIA1 (m2), was significantly higher in patients with PD (0.444) than in controls (0.349). The risk of PD in homozygotes for m2 was 2.34-fold greater than homozygotes for the wild-type, m1. The relative risk for PD in homozygotes for CYPIA1Val was 6.54-fold higher than in homozygotes for the wild type (CYPIA1Ile)(p < 0.001). These results strongly suggest that the CYPIA1 might be one of the susceptibility genes for PD.
引用
收藏
页码:843 / 849
页数:7
相关论文
共 23 条
[1]   GENETIC-POLYMORPHISM OF INDUCTION OF CYP1A1 (EROD) ACTIVITY [J].
CATTEAU, A ;
DOURIEZ, E ;
BEAUNE, P ;
POISSON, N ;
BONAITIPELLIE, C ;
LAURENT, P .
PHARMACOGENETICS, 1995, 5 (02) :110-119
[2]   ELECTROPHYSIOLOGICAL ACTIONS OF NICOTINE ON SUBSTANTIA NIGRA SINGLE UNITS [J].
CLARKE, PBS ;
HOMMER, DW ;
PERT, A ;
SKIRBOLL, LR .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 85 (04) :827-835
[3]  
FARIN FM, 1993, J TOXICOL ENV HLTH, V40, P323
[4]   SUBCELLULAR-LOCALIZATION OF CYTOCHROME-P450, AND ACTIVITIES OF SEVERAL ENZYMES RESPONSIBLE FOR DRUG-METABOLISM IN THE HUMAN BRAIN [J].
GHERSIEGEA, JF ;
PERRIN, R ;
LEININGERMULLER, B ;
GRASSIOT, MC ;
JEANDEL, C ;
FLOQUET, J ;
CUNY, G ;
SIEST, G ;
MINN, A .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (03) :647-658
[5]   SMOKING AND PARKINSONS-DISEASE - SEARCH FOR A DOSE-RESPONSE RELATIONSHIP [J].
GOLBE, LI ;
CODY, RA ;
DUVOISIN, RC .
ARCHIVES OF NEUROLOGY, 1986, 43 (08) :774-778
[6]   ROLE OF HUMAN CYTOCHROMES P450 IN THE METABOLIC-ACTIVATION OF CHEMICAL CARCINOGENS AND TOXINS [J].
GONZALEZ, FJ ;
GELBOIN, HV .
DRUG METABOLISM REVIEWS, 1994, 26 (1-2) :165-183
[7]  
GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243
[8]   GENETIC-LINKAGE OF LUNG CANCER-ASSOCIATED MSPI POLYMORPHISMS WITH AMINO-ACID REPLACEMENT IN THE HEME BINDING REGION OF THE HUMAN CYTOCHROME-P450IA1 GENE [J].
HAYASHI, S ;
WATANABE, J ;
NAKACHI, K ;
KAWAJIRI, K .
JOURNAL OF BIOCHEMISTRY, 1991, 110 (03) :407-411
[9]   BIOCHEMICAL INDIVIDUALITY AND ITS IMPLICATIONS FOR DRUG AND CARCINOGEN METABOLISM - RECENT INSIGHTS FROM ACETYLTRANSFERASE AND CYTOCHROME P4501A2 PHENOTYPING AND GENOTYPING IN HUMANS [J].
KADLUBAR, FF .
DRUG METABOLISM REVIEWS, 1994, 26 (1-2) :37-46
[10]  
KONDO K, 1973, MAYO CLIN PROC, V48, P465